SHERBURN GROUP PRACTICE
BEECH GROVE, SHERBURN IN ELMET, LEEDSCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 242 | 257 | 94.2% | |
CHD 9 | 2006 | 258 | 264 | 97.7% | |
CHD 9 | 2007 | 259 | 264 | 98.1% | |
CHD 9 | 2008 | 253 | 260 | 97.3% | |
CHD 9 | 2009 | 250 | 257 | 97.3% | |
CHD 9 | 2010 | 263 | 271 | 97.0% | |
CHD 9 | 2011 | 271 | 285 | 95.1% | |
CHD 9 | 2012 | 268 | 286 | 93.7% | |
CHD 9 | 2013 | 270 | 286 | 94.4% | |
CHD005 | 2014 | 285 | 295 | 96.6% | |
CHD005 | 2015 | 282 | 284 | 99.3% | |
CHD005 | 2016 | 293 | 297 | 98.7% | |
CHD005 | 2017 | 311 | 316 | 98.4% | |
CHD005 | 2018 | 303 | 307 | 98.7% | |
CHD005 | 2019 | 297 | 306 | 97.1% | |
CHD005 | 2020 | 296 | 305 | 97.0% | |
CHD005 | 2021 | 285 | 306 | 93.1% | |
CHD005 | 2022 | 285 | 293 | 97.3% | |
CHD005 | 2023 | 295 | 318 | 92.8% |